1.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
by Mahmoodi, Bakhtawar K, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1649-1661

2.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559

3.
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
by Xie, Xinfang, MD
The Lancet (British edition), 2016, Vol.387 (10017), p.435-443

4.
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
by Woodward, Mark
Heart (British Cardiac Society), 2007-02, Vol.93 (2), p.172-176

5.
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by Welsh, Paul
Diabetologia, 2018-05-04, Vol.61 (7), p.1581-1591

6.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474

7.
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
by Oshima, Megumi
Diabetologia, 2019-07-13, Vol.62 (11), p.1988-1997

8.

9.
Socioeconomic disadvantage and disease-specific mortality in Asia: systematic review with meta-analysis of population-based cohort studies
by Vathesatogkit, Prin
Journal of Epidemiology and Community Health, 2014-04, Vol.68 (4), p.375-383

10.
Referral for Specialist Follow-Up and its Association with Post-Discharge Mortality among Patients with Systolic Heart Failure (From the National Heart Failure Audit for England &...
by Emdin, Connor A., HBSc
The American journal of cardiology, 2016, Vol.119 (3), p.440-444

11.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2

12.
Full hazards of smoking and benefits of stopping for women
by Huxley, Rachel R
The Lancet (British edition), 2013, Vol.381 (9861), p.96-98

13.
Predicting the risk of physical disability in old age using modifiable mid-life risk factors
by Wong, Evelyn
Journal of epidemiology and community health (1979), 2015-01, Vol.69 (1), p.70-76

14.
Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality
by Woodward, M
Journal of epidemiology and community health (1979), 1999-08, Vol.53 (8), p.481-487

15.
Obesity, overweight and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424 519 participants
by Parr, Christine Louise Christine Louise
The lancet oncology, 2010-06-30, Vol.11 (8), p.741-752

16.
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
by Matsushita, Kunihiro
The Lancet (British edition), 2010, Vol.375 (9731), p.2073-2081

17.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
by Fox, Caroline S, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1662-1673

18.
Small area statistics as markers for personal social status in the Scottish heart health study
by Woodward, M
Journal of epidemiology and community health (1979), 1996-10, Vol.50 (5), p.570-576

19.
Analysis of the Benefits of a Mediterranean Diet in the GISSI-Prevenzione Study: A Case Study in Imputation of Missing Values from Repeated Measurements
by BARZI, Federica
European journal of epidemiology, 2006-01-01, Vol.21 (1), p.15-24

20.
An Economic Evaluation of a Perindopril-Based Blood Pressure Lowering Regimen for Patients Who Have Suffered a Cerebrovascular Event
by Tavakoli, Manouchehr
The European journal of health economics, 2009-02-01, Vol.10 (1), p.111-119
